MEGGLE returns to CPhI China in Shanghai
Press Release | MEGGLE Excipients & Technology
JUNE 07, 2019
Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Excipients &Technology (MEGGLE) will again be a prominent presence at this year’s huge CPhI China expo in Shanghai, presenting its innovative range of lactose-based pharmaceutical agents and excipients to the growing Asian market.
As before, MEGGLE will be exhibiting in partnership with local partners Guangzhou Standard Pharma Ltd. and Shanghai Pintech Pharmaceutical Co., Ltd., this time from Booth E3E02 at Shanghai’s SNIEC Exhibition Center.
The MEGGLE display will feature the whole range of MEGGLE lactose-based and co-processed products for dry granulation and wet granulation, including the ground-breaking Tablettose® and FlowLac® spray-dried alpha-lactose monohydrates, both of which have helped revolutionize direct compression tableting.
MEGGLE will also show Cellactose®, GranuLac® and the InhaLac® grades.
InhaLac 500 the micronized DPI Lactose comes with a further key benefit of a long shelf life. This leads into a high stability and a retest date of 18 month.
Video screens on the stand will provide visitors with insights into MEGGLE’s rigorous production standards, advanced technology and pioneering research work.
“CPhIChina has become a key exhibition for pharmaceutical companies, not just in China or across Asia, but also worldwide,” commented Dr. Yi Kang, Director MEGGLE Shanghai, who will lead the team at the event.
About MEGGLE Wasserburg
Bavarian-based MEGGLE Wasserburg is one of the world’s experts in lactose-based excipients and powder technology.
From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.
MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.
A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage form applications, where they can deliver maximum performance.
The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for modified sustained release and controlled release formulations.
About CPhI China 2019
Since Y2000, CPhI China has established itself as the leading pharma industry business and sourcing event for Eastern Asia, reflecting the huge growth of the Chinese pharma market.
CPhI China is a three-day event opening June 18 at the Shanghai New International Exhibition Center (SNIEC) and is co-located with five other pharma industry events, P-Mec for machinery and equipment, ICSE for outsourcing solutions BioPh for biotech solution, InnoPack for Drug Packaging and Delivery Technology and LABWorld for laboratory equipment. Together, the shows bring together some 3,000 suppliers, attracting around 40,000 visitors from more than 100 countries.
CPhI & P-MEC China also part of the wider China Pharma Week that features some 14 events focusing on Business, Knowledge, Leadership, Innovation, Recognition and Networking in the field of Pharma.
CPhI China is organized by Informa Markets with further information at http://www.cphi-china.cn/en
Margit Bonnetsmüller, Project Manager Marketing, MEGGLE Excipients &Technology Business Group
Tel: +49 8071 73 476